Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.58 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.57 |
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | CA3 | P07451 | 2/20 | 0.57 |
| ▸ | CA4 | P22748 | 2/20 | 0.57 |
| ▸ | CA6 | P23280 | 2/20 | 0.57 |
| ▸ | CA5A | P35218 | 2/20 | 0.57 |
| ▸ | CA7 | P43166 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.57 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31240836 | 1.00 | CHRM2 (0.58) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL1273916 | 1.00 | CHRM2 (0.58) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL27297758 | 1.00 | CHRM2 (0.58) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL16213062 | 0.97 | CHRM2 (0.55) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL28300321 | 0.97 | CHRM2 (0.55) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL560600 | 0.97 | CHRM2 (0.55) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL817873 | 0.97 | CHRM2 (0.55) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL63987 | 0.96 | NFKB1 (0.54) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL27296654 | 0.96 | NFKB1 (0.54) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL817594 | 0.94 | CHRM2 (0.52) | CHRM2DNM1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022207920-A1 | MULTIBRANCHED POLYMERS, COMPOSITIONS COMPRISING SAME, METHODS FOR PREPARING SAME, AND USE THEREOF IN ELECTROCHEMISTRY | SCE FRANCE (FR) | 2022-10-06 | — | — | WO | claimed |
| US-9809719-B2 | Cationic paint additives | ALLNEX AUSTRIA GMBH (AT) | 2017-11-07 | — | — | US | claimed |
| US-7645855-B2 | Condensation, solution polymerization of carbonates with diamines | BASF AKTIENGESELLSCHAFT (DE) | 2010-01-12 | — | — | US | claimed |
| WO-2009027186-A2 | HYPERBRANCHED POLYMERS COMPRISING GUANIDINE UNITS | BASF SE (DE) | 2009-03-05 | — | — | WO | claimed |
| US-20080306237-A1 | Highly Functional, Highly Branched Polyureas | BASF AKTIENGESELLSCHAFT (DE) | 2008-12-11 | — | — | US | claimed |
| EP-1716197-B1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF SE (DE) | 2008-10-29 | — | — | EP | claimed |
| EP-1685181-B1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF SE (DE) | 2008-08-20 | — | — | EP | claimed |
| US-20070083030-A1 | Highly functional, highly branched polyureas | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | claimed |
| EP-1716197-A1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-02 | — | — | EP | claimed |
| EP-1685181-A1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-02 | — | — | EP | claimed |
| WO-2005075541-A1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-18 | — | — | WO | claimed |
| WO-2005044897-A1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-19 | — | — | WO | claimed |
| US-12612482-B2 | Combination of crosslinkers to improve coating properties | BASF SE (DE) | 2026-04-28 | — | — | US | disclosed |
| US-20260092157-A1 | MACROPOROUS-STRUCTURED POLYMER AEROGELS | BLUESHIFT MAT INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-12516172-B2 | Macroporous-structured polymer aerogels | Blueshift Materials, Inc. (US) | 2026-01-06 | — | — | US | disclosed |
| EP-4655158-A2 | FLAME AND THERMAL BARRIER MATERIALS | Blueshift Materials, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| WO-2003066702-A1 | METHOD FOR THE PRODUCTION OF HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-14 | — | — | WO | disclosed |
| US-6184336-B1 | USEFUL AS CHELANTS IN WATER TREATMENT | NALCO CHEMICAL COMPANY | 2001-02-06 | — | — | US | disclosed |
| US-5929198-A | HIGH MOLECULAR WEIGHT POLYMERS MODIFIED WITH N-DERIVATIZED COMPOUNDS | NALCO CHEMICAL COMPANY (US) | 1999-07-27 | — | — | US | disclosed |
| EP-0832851-A1 | Biodegradable poly (amino acids), derivatized amino acid polymers and methods for making the same | Nalco Chemical Company (US) | 1998-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612482-B2 | Combination of crosslinkers to improve coating properties | BHMT2, FDFT1, MNAT1 | CHRM2 1294/4885DNM1 3460/4885CA12 3904/4885 |
| US-20260092157-A1 | MACROPOROUS-STRUCTURED POLYMER AEROGELS | ACR, AQP4, AQP3 | CHRM2 3456/4885DNM1 2462/4885CA12 1079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.